2025
SJR Q2
JCR Q2 · 3,6
156 matched articles
SCIE
Journal detail
Current Pharmaceutical Analysis
- Publisher
- KeAi Communications Co.
- Country
- China · Asiatic Region
- Type
- journal
- ISSN
-
157341291875676X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,442
- Quartile Q2
- H-Index 32
- Cites/doc 3,73
- Docs (3y) 208
- Cites (3y) 553
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,6
- 5Y JIF 1,6
- JCI 0,51
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,442 | 3,6 | 1,6 | 0,51 | Q3 | 32 |
| 2024 | Q3 | Q4 | 0,236 | 1,5 | 0,9 | 0,21 | Q4 | 29 |
| 2023 | Q3 | Q4 | 0,184 | 0,7 | 0,7 | 0,19 | Q4 | 29 |
| 2022 | Q3 | Q4 | 0,178 | 0,6 | 0,6 | 0,18 | Q4 | 29 |
| 2021 | Q3 | Q4 | 0,177 | 0,7 | 0,7 | 0,23 | Q4 | 29 |
| 2020 | Q3 | Q4 | 0,21 | 0,9 | 0,8 | 0,28 | Q4 | 29 |
| 2019 | Q2 | Q4 | 0,286 | 0,9 | 0,9 | 0,33 | Q4 | 29 |
| 2018 | — | Q4 | — | 0,8 | 0,8 | 0,28 | Q4 | — |
| 2017 | Q3 | Q4 | 0,224 | 0,9 | 0,8 | 0,32 | Q4 | 29 |
| 2016 | Q3 | Q4 | 0,242 | 0,8 | 0,6 | — | — | 29 |
| 2015 | Q3 | Q4 | 0,224 | 0,9 | 0,6 | — | — | 29 |
| 2014 | Q3 | Q4 | 0,243 | 0,7 | 0,8 | — | — | 29 |
| 2013 | Q2 | Q4 | 0,294 | 0,8 | 1,1 | — | — | 29 |
| 2012 | Q2 | Q3 | 0,425 | 1,3 | 1,1 | — | — | 29 |
| 2011 | Q2 | Q4 | 0,417 | 1,2 | 1 | — | — | 29 |
| 2010 | Q2 | Q3 | 0,503 | 1,7 | 1,5 | — | — | 29 |
| 2009 | — | Q4 | — | 1,2 | 1,4 | — | — | — |
| 2008 | — | Q4 | — | 1 | 1,3 | — | — | — |
| 2007 | — | Q4 | — | 1,2 | 1,2 | — | — | — |
| 2006 | — | Q4 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 128/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 267/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 317/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 267/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 266/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 263/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 249/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 244/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 239/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 235/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 229/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 228/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 218/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 188/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 201/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 158/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 185/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 177/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 157/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 150/199 |